Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03682796
Title Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Triphase Research and Development III Corp.
Indications

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

Therapies

TRPH-222

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Banner MD Anderson Gilbert Arizona 85234 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43219 United States Details
Abramson Cancer Center of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Jewish General Hospital Montréal Quebec H3T 1E2 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field